Contact Us Menu

Our Leadership

Close

Sujay Jadhav, MBA

Chief Executive Officer

Sujay Jadhav is the Chief Executive Officer at Verana Health where he is helping to accelerate the company’s growth and sustainability by advancing clinical trial capabilities, data-as-a-service offerings, medical society partnerships, and data enrichment.

Sujay joins Verana Health with more than 20 years of experience as a seasoned executive, entrepreneur, and global business leader. Most recently, Sujay was the Global Vice President, Health Sciences Business Unit at Oracle, where he ran the organization’s entire product and engineering teams. Before Oracle, Sujay was the CEO of cloud-based clinical research platform goBalto, where he oversaw the acquisition of the company by Oracle. Sujay is also a former executive for the life sciences technology company Model N, where he helped to oversee its transition to a public company.

Sujay holds an MBA from Harvard University and a bachelor’s degree in electronic engineering from the University of South Australia.

Sujay Jadhav, MBA on LinkedIn
Sujay Jadhav, <span>MBA</span>

Why Verana?

“We are at an inflection point in digital health. We now have the opportunity to transform patient care and cure by extracting quality insights from unfiltered, real-world healthcare data. Verana Health is poised to affect real change by defining and delivering the highest standards of data integrity to power healthcare."

Marc Berger, Esq, MBA

Chief Operations Officer

Marc Berger is Chief Operations Officer at Verana Health. He was previously Senior Vice President at Verana Health and a member of the core leadership team responsible for setting Verana Health’s corporate strategy. He served as the company’s General Counsel and Privacy Officer and was responsible for the company’s legal functions, including corporate, privacy, commercial contracting, health law, and intellectual property activities. As Senior Vice President, he also oversaw Verana Health’s Security & Compliance and People & Culture teams.

Prior to joining Verana Health, Marc was General Counsel at Flatiron Health, where he was a member of the four-person team that negotiated the $2.1B acquisition by Roche. Marc has also served as Vice President and Assistant General Counsel at Medidata Solutions, where he had global responsibility for negotiating agreements with life science companies and partners for Medidata’s clinical trial technology and service offerings.

Marc received his JD and MBA from the University of Miami School of Law, and his BS in Management and International Business from Penn State University.

Marc Berger, Esq, MBA on LinkedIn
Marc Berger, <span>Esq, MBA</span>

Why Verana?

I love working at mission-driven companies. Verana’s deep commitment to improving patient care and accelerating scientific research with clinical data is something the entire organization is behind.

Andrea Sim

Chief Product Officer

Andrea Sim is the Chief Product Officer at Verana Health where she oversees product management, program management, clinical informatics, and data normalization.

Andrea has more than two decades of product management and healthcare technology experience. Prior to joining Verana Health, Andrea was the Vice President of Product for the Health Sciences Business Unit at Oracle. Andrea came to Oracle through the acquisition of goBalto, Inc., where she also was the Vice President of Product. Before that, Andrea was with RelayHealth for nearly a decade, where she most recently served as Vice President of Product Management. She was part of the product management team for more than six years, holding responsibility for product strategy, research, and strategic initiatives for Health Information Exchange (HIE) and clinical integration. Before that, Andrea served in various product management and consulting roles for Oracle, WebMD, and First Consulting Group.

Andrea holds a Bachelor of Arts degree in Molecular Cell Biology from University of California Berkeley.

Andrea Sim on LinkedIn
Andrea Sim

Why Verana?

Getting to use my experience in healthcare technology product management to make an impact on the quality of patient care is rewarding. What Verana Health is doing is important, difficult, and exciting. Each day is a challenge that’s full of opportunities to grow and innovate.

Lawrence Whittle

Chief Commercial Officer

Lawrence Whittle is Chief Commercial Officer based in California. Lawrence is responsible for driving the market positioning and customer success at Verana Health. His remit spans a multitude of stakeholders, leading medical society engagement, healthcare provider experience, and life sciences partnerships, as well as the marketing and quantitative sciences functions to elevate awareness and value across the care continuum.

Lawrence has 25+ years experience as a senior executive within technologies companies spanning different industries, including Data Analytics and Life Sciences. His deep expertise in commercialization has covered elevating company positioning, driving sustainable customer value through deep in-market partnerships, and nurturing strong collaborations across all key functions of the business. His experience in early- and mid-stage companies has resulted in two IPOs and two M&A transactions.

Lawrence was born in London and is a true global citizen, having worked across many countries. He has been based in California since 2008 where he lives with his wife and three children.

Lawrence Whittle on LinkedIn
Lawrence Whittle

Why Verana?

I have been fortunate to work at several amazing companies that have used advanced technology to enhance business outcomes, but the Verana Health mission is truly unique and inspirational. It’s exciting to have the opportunity to utilize a significant and highly differentiated data set to drive major improvements to the speed and efficacy of healthcare across multiple therapeutic areas. I am honored to be part of this motivational Verana Health mission to help improve healthcare outcomes.

Chris Reiling

Chief Revenue Officer

Chris Reiling is the Chief Revenue Officer for Verana Health. Chris leads the sales team and is responsible for the company’s revenue generation strategy and execution as well as its go-to-market approach.

Chris is a sales and account management executive with more than 15 years of experience scaling revenue and growth by optimizing sales processes, business development, strategic alliances, market positioning, and commercialization—primarily focused on healthcare data and technology. Prior to joining Verana Health, Chris held varying sales leadership roles at IQVIA across its life sciences and MedTech business, with his most recent responsibilities leading the U.S. Real World Data & Technology sales team.

Chris holds a BA in Economics from The University of Connecticut.

Chris Reiling on LinkedIn
Chris Reiling

Why Verana?

I have always been fascinated by the power of what data can bring to decision making, specifically in healthcare and drug development. Verana Health’s mission to leverage deep real-world data in conjunction with scientific rigor and technology excites me. It’s an honor to be part of this journey and support our efforts in unlocking the promise of reducing clinical development costs, so life enhancing therapeutics can get to patients faster.

Kirk Fjeldheim

Chief Information Security Officer

Kirk Fjeldheim is Chief Information Security Officer, where he is responsible for Verana Health’s data, infrastructure and corporate protection strategies, which include identifying, developing, implementing, and maintaining processes across product and corporate systems. Kirk also manages corporate IT and Compliance. Kirk Fjeldheim brings several decades of experience at high-growth technology companies to Verana Health. Prior to joining Verana Health, Kirk was Chief Information Security Officer at Syapse, Inc. and Chief Information Officer at SugarCRM. As Vice President of IT and Security at Rally Health, he led Security, compliance and IT for more than 1,400 employees and developed and implemented HIPAA compliance and risk management efforts for a customer application reaching 38 million users. He has also held senior IT positions at Zynga, Xsigo Systems, Openwave Systems, and Siebel Systems.

Kirk Fjeldheim on LinkedIn
Kirk Fjeldheim

Why Verana?

Insights from health data are a critical component of improving the lives of people all over the world. I am thrilled to work at a company where technologists and data scientists are working together to improve quality of care and to advance medical research.

Chidambaram Arunachalam

Senior Vice President of Engineering

Chidambaram “Chidhi” Arunachalam is Senior Vice President of Engineering, where he is responsible for leading the ingestion, curation, and applications teams at Verana Health.

Chidhi has more than 20 years of experience in engineering management, which includes leading product development across life sciences, healthcare, product lifecycle management and computer-aided design domains. Prior to joining Verana Health, Chidhi was the Global Vice President of Product Development for the Health Sciences Business Unit at Oracle, where he was responsible for various functions of software development and deployment. The products he helped to develop include a complete set of clinical and safety solutions that supported critical processes throughout the clinical development lifecycle – from study design and startup to conduct, close-out, and post-marketing.

Chidambaram Arunachalam on LinkedIn
Chidambaram Arunachalam

Why Verana?

Utilizing technology and building upon teams to help solve problems is exciting. Verana Health is helping to accelerate the delivery of quality of care, which will help ease the burden on patients and healthcare providers. It is a privilege to be involved in such a critical mission.

Aracelis Torres, PhD, MPH

Senior Vice President, Customer Solutions and Quantitative Sciences

Aracelis Torres, PhD, MPH is Senior Vice President of Customer Solutions and Quantitative Sciences, where she oversees the quantitative sciences team working to develop and implement rigorous methodology to generate sound scientific evidence from real-world data. Dr. Torres is an epidemiologist with over ten years of academic and industry experience. Prior to joining Verana Health, she was a Director of Quantitative Sciences at Flatiron Health, where her work focused on translation of real-world oncology data to generate evidence. While at Flatiron Health, she led efforts related to the development of real-world endpoints, novel study designs, and prospective evidence generation while also serving as the Quantitative Sciences lead for the organization’s broader research collaboration with the FDA. She is also currently an Adjunct Professor at Columbia University Graduate School of Arts and Sciences, where she teaches a course on large-scale data processing and analysis. 

Dr. Torres received a PhD in Cancer Epidemiology from Johns Hopkins Bloomberg School of Public Health, an MPH in Chronic Disease Epidemiology from Yale University’s School of Public Health, and a BS in Molecular, Cellular, and Developmental Biology from Yale University.

Aracelis Torres, PhD, MPH on LinkedIn
Aracelis Torres, <span>PhD, MPH</span>

Why Verana?

Verana’s mission to rigorously generate insights from real-world data is both inspiring and exciting. It provides a unique opportunity to tackle some of the toughest challenges in clinical research while keeping patients at the forefront of our work.

Ann Watson

Senior Vice President,
People & Culture

Ann Watson is Verana Health’s Senior Vice President of People and Culture, bringing a passion for building teams to Verana Health’s next phase of growth. The People & Culture team is responsible for all phases of the employee lifecycle: from finding great people to supporting their development all the way through to the alumni phase. Ann has over twenty years of experience in Human Resources and Talent Acquisition, primarily with small and mid-sized technology organizations. Ann was previously the Chief People Officer at MasterClass, at Varo Bank, and ran the Employee Experiences organization at Fandom. She specializes in growing teams from 50 to 500+, doubling the team multiple years in a row, building infrastructure to scale through the early start-up stage to mid-size maturity and beyond.

Ann has a BA from Santa Clara University and is a member of PeopleTechPartners, an organization devoted to accelerating solutions that drive the future of work.

Ann Watson on LinkedIn
Ann Watson

Why Verana?

In addition to being drawn to the incredible mission of improving patient outcomes, the people are why I chose Verana. It is an incredible privilege to work with this team and I’m very appreciative of the overall lack of jerks. Verana is doing great work with great people!

Ray Goforth

Senior Vice President of Marketing

Ray has more than 15 years of digital marketing experience and has led marketing strategies for lean startups, as well as global enterprise organizations. She excels in creating meaningful experiences for targeted audiences that drive engagement, return on investment, and customer loyalty. She’s led various digital engagements, including developing and overseeing large multifaceted growth strategies, global product launches, and go-to-market programs. She also has helped facilitate multiple successful acquisitions. Ray has a bachelor’s degree in Psychology from the University of Oklahoma.

Ray Goforth on LinkedIn
Ray Goforth

Why Verana?

I chose to join Verana Health because of the opportunity to apply my marketing skills at an organization that strives to positively impact the health and wellbeing of patients. I’m also fortunate to work alongside talented individuals who have expertise in multiple areas of digital health technology.

Dominique Connolly, RN, NP

Vice President of Clinical Data Strategy

Dominique Connolly, RN, BSN, MA, serves on the Medical team as the Vice President of Clinical Data Strategy at Verana Health. Connolly is a Nurse Practitioner with more than 20 years of experience in healthcare and oncology, with a recent focus in optimizing approaches for data curation, as well as building and scaling teams. Prior to joining Verana Health, Connolly served at Flatiron Health as Senior Clinical Director for the Research Platforms team, as well as Director of Clinical Data Abstraction, where she built and oversaw the unstructured data processing efforts. She earned a Bachelor of Nursing degree from the University of Pennsylvania and a Master of Nursing degree from New York University.

Dominique Connolly, RN, NP on LinkedIn
Dominique Connolly, <span>RN, NP</span>

Why Verana?

Our overall goal is to help patients by getting the treatments that work to those who need them faster and more effectively.

Yana Nikitina

Vice President of Engineering

Yana Nikitina is Vice President of Engineering, where she leads technology strategy and product development.

Yana brings over two decades of experience of building scalable, compliant, resilient, interoperable products. In the past years, she focused on accelerating growth in the Fintech space (LendingClub, Varo Bank and Braintree/PayPal). Yana held leadership roles in Data Platform, Actionable Insights, Mobile bank app, Payment Processing and Commerce Payment Platform.

Yana holds a BS in Computer Science from UC Davis.

 

Yana Nikitina on LinkedIn
Yana Nikitina

Why Verana?

Verana's mission strongly aligns with my personal values. I believe it will make a positive real-world impact and improve lives and I am excited to advance the application of innovative technologies to accelerate research in medicine.

Michelle McGovern, Esq, MS

General Counsel

Michelle McGovern is the General Counsel at Verana Health, where she works to find solutions that help set the market standard for data privacy in an increasingly complex legal environment.  Michelle was previously the Deputy General Counsel at Redesign Health, a venture-backed incubator that, during her tenure, raised $350M, and built, launched and scaled more than two dozen healthcare companies. Michelle also worked at Pfizer, where her roles included supporting clinical trials and pharmacovigilance, building sustainable markets for pharmaceutical products in the developing world, and serving as the North America Legal Lead for Upjohn, Pfizer’s $12B legacy products and generics business.

Michelle completed Northwestern University’s accelerated journalism degree program, graduating in four years, magna cum laude, with a Bachelor’s of Science and Master’s of Science in Journalism, and received her JD, cum laude, from Northwestern University’s Pritzker School of Law. Michelle has been credentialed by the International Association of Privacy Professionals as a Certified Information Privacy Manager. Michelle is also the President of the Board of Directors of 826NYC, a charity that helps under-resourced youth write their own paths forward, regardless of circumstance.

Michelle McGovern, Esq, MS on LinkedIn
Michelle McGovern, <span>Esq, MS</span>

Why Verana?

It is a privilege to work for a company that strives to improve the lives of patients, while serving as a steward of their health information. The importance of what we do, and of who we serve, inspires me to approach legal questions with both creativity and care.

Almer Mendoza, MBA

Vice President Controller

Almer Mendoza, Vice President Controller, brings more than 20 years of experience in corporate finance, accounting, and auditing. Prior to joining Verana Health, Almer was VP Corporate Controller at Navis LLC – a leading provider of global cargo handling software, where he managed the worldwide accounting in more than 20 countries. Prior to Navis, he was VP Finance or Corporate Controller in several public and private technology companies, where he built accounting teams, completed first audits, helped prepare for initial public filings, implemented ERPs, and integrated acquired companies. He started his career as an auditor at Ernst and Young LLP.

Almer received his MBA from Pepperdine University, and his BS in Accounting from Northwestern State University. He is a licensed Certified Public Accountant.

Almer Mendoza, MBA on LinkedIn
Almer Mendoza, <span>MBA</span>

Why Verana?

Verana’s data platform that helps accelerate healthcare innovation and drug development excites me. I have been wanting to join a Company that help people. I am motivated to contribute to the success of the Company.

Michael Mbagwu, MD

Senior Medical Director

Michael Mbagwu, MD, Senior Medical Director, serves on the Medical Team as the Lead IRIS Registry Oversight Physician at Verana Health. He attended The Ohio State University where he completed a Bachelor of Science in Biomedical Science and graduated Summa Cum Laude. He subsequently attended Northwestern University Feinberg School of Medicine, where he received a Doctor of Medicine and graduated Cum Laude in Scientia Experimentalis. He also completed a Transitional/Medical internship year at Presence Resurrection Medical Center before returning to Northwestern to complete his residency training in Ophthalmology, where he served as Chief Resident. Dr. Mbagwu went on to complete an Ophthalmic Innovation Fellowship at the Byers Eye Institute/Stanford University School of Medicine. Dr. Mbagwu currently holds the academic rank of Adjunct Clinical Instructor of Ophthalmology at Stanford University School of Medicine and is an attending physician with the Department of Veterans Affairs, Palo Alto Health Care System.

Michael Mbagwu, MD on LinkedIn
Michael Mbagwu, <span>MD</span>

Why Verana?

Verana Health resides at the unique intersection of clinical data, real-world evidence expertise, and creation of innovative solutions. As a practicing ophthalmologist, it is inspiring for me to collaborate on projects that I know will improve quality of care for the patients I see. There's truly no place like it, and I'm excited to be a part of the important work we do.

Sujay Jadhav, MBA Chief Executive Officer Sujay Jadhav, MBA on LinkedIn
Marc Berger, Esq, MBA Chief Operations Officer Marc Berger, Esq, MBA on LinkedIn
Andrea Sim Chief Product Officer Andrea Sim on LinkedIn
Lawrence Whittle Chief Commercial Officer Lawrence Whittle on LinkedIn
Chris Reiling Chief Revenue Officer Chris Reiling on LinkedIn
Kirk Fjeldheim Chief Information Security Officer Kirk Fjeldheim on LinkedIn
Chidambaram Arunachalam Senior Vice President of Engineering Chidambaram Arunachalam on LinkedIn
Aracelis Torres, PhD, MPH Senior Vice President, Customer Solutions and Quantitative Sciences Aracelis Torres, PhD, MPH on LinkedIn
Ann Watson Senior Vice President,
People & Culture
Ann Watson on LinkedIn
Ray Goforth Senior Vice President of Marketing Ray Goforth on LinkedIn
Dominique Connolly, RN, NP Vice President of Clinical Data Strategy Dominique Connolly, RN, NP on LinkedIn
Yana Nikitina Vice President of Engineering Yana Nikitina on LinkedIn
Michelle McGovern, Esq, MS General Counsel Michelle McGovern, Esq, MS on LinkedIn
Almer Mendoza, MBA Vice President Controller Almer Mendoza, MBA on LinkedIn
Michael Mbagwu, MD Senior Medical Director Michael Mbagwu, MD on LinkedIn

Our Medical Advisors

Close
Jennifer Bepple, MD

Urology

Durga Borkar, MD, MMCI

Ophthalmology

Theodore Leng, MD, MS

Ophthalmology

Heather Moss, MD, PhD

Neurology, Ophthalmology

Our Advisors

Close
Mark Blumenkranz, MD

Co-Founder,
Verana Health and Lagunita Biosciences

Jennifer Cook

Strategic Advisor

Steven Schwartz, MD

Ahmanson Professor in Ophthalmology,
Stein Eye Institute, UCLA

Our Board

Close

David W. Parke II, MD
(Executive Chairman)

Former Chief Executive Officer

David W. Parke II, M.D.
Dr. Parke served from 2009 to 2022 as the Chief Executive Officer of the American Academy of Ophthalmology. He is now Executive Chairman of Verana Health, Inc. and remains CEO Advisor at the Academy.
After undergraduate education at Stanford University and medical school of Baylor College of Medicine, Dr. Parke completed residency training and chief residency at Baylor’s Cullen Eye Institute followed by fellowships in diseases and surgery of the retina and vitreous.
He served for 17 years as president and chief executive officer of the Dean McGee Eye Institute and Professor and Chair of the Department of Ophthalmology at the University of Oklahoma. After serving as president of the American Academy of Ophthalmology in 2008, Dr. Parke was chosen to become its full-time CEO.
He has served on the boards of companies in the insurance and digital health space. He is Past-President of the Council of Medical Specialty Societies.
Dr. Parke has been president of the Association of University Professors of Ophthalmology and director of the American Board of Ophthalmology. In 2009 he was elected to Academia Ophthalmologica Internationalis.
His most recent professional and scholarly activities have centered on health policy and economics, on biomedical organizational leadership and development, and on big data analytics.

David W. Parke II, MD<br><span>(Executive Chairman)</span>
David W. Parke II, MD
(Executive Chairman)

Former Chief Executive Officer,
American Academy of Ophthalmology

Brook Byers

Founding Partner,
Kleiner, Perkins, Caufield & Byers

Sujay Jadhav, MBA

CEO,
Verana Health

Jeffrey Low, MD, MBA

Principal,
Novo Growth

Mary E. Post, MBA, CAE

Chief Executive Officer,
American Academy of Neurology

Michael T. Sheppard, CPA, CAE

Chief Executive Officer,
American Urological Association

Julie Sunderland

Co-Founder and Managing Director,
Biomatics Capital Partners

Asish K. Xavier, PhD, MBA

VP of Venture Investments,
Johnson & Johnson Innovation - JJDC, Inc.

Krishna Yeshwant, MD

Managing Partner,
GV

Brendan Bulik-Sullivan
(Observer)

Partner,
GV

Eli Casdin
(Observer)

Chief Investment Officer and Founder,
Casdin Capital

Joel Krikston, MBA
(Observer)

Managing Director,
Merck Global Health Innovation Fund

Our Investors

Verana Health is backed by leading institutional investors and industry veterans:

Google Ventures
Casdin Capital
Define Ventures
Biomatics Capital
Lagunita Biosciences
Revelation Partners
Johnson & Johnson Innovation
Novo Holdings

Brook Byers, founding member and senior partner of Kleiner, Perkins, Caufield, and Byers.